Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synergy CHCSNYR +34.66% 14-Day RSI is 44.80 as of Sep. 10, 2026. The stock has 3 warning signs investors should review. Among 129 Medical Distribution companies, Synergy CHC ranks better than 88.37% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-09-10), Synergy CHC's 14-Day RSI is 44.80.
The industry rank for Synergy CHC's 14-Day RSI or its related term are showing as below:
SNYR's 14-Day RSI is ranked better than 88.37% of 129
companies
in the Medical Distribution industry
Industry Median: 49.56
vs SNYR: 44.80
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Synergy CHC 14-Day RSI Related Terms
SNYR vs MEDS, MCK, COR: 14-Day RSI Comparison
For the Medical Distribution subindustry, Synergy CHC's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synergy CHC 14-Day RSI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Synergy CHC's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Synergy CHC's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synergy CHC (SNYR) has a 14-Day RSI of 44.80 as of Sep. 10, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Synergy CHC and its competitors. According to the industry distribution chart, Synergy CHC ranks #15 out of 129 companies in the Medical Distribution industry, placing it in the top 11.6%.
Is Synergy CHC's 14-Day RSI too high?
Synergy CHC's current 14-Day RSI is 44.80. The Medical Distribution industry median 14-Day RSI is 49.56. Synergy CHC's value of 44.80 is 9.6% below this industry median. Based on the distribution chart, Synergy CHC ranks #15 out of 129 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers.
How does Synergy CHC's 14-Day RSI compare to MEDS and MCK?
According to the Medical Distribution industry distribution chart, Synergy CHC ranks #15 out of 129 companies for 14-Day RSI. This places Synergy CHC in the top 12% of its industry — outperforming the majority of peers. The industry median 14-Day RSI is 49.56. Synergy CHC's value of 44.80 is 9.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Distribution company?
The median 14-Day RSI among Medical Distribution companies is 49.56, based on 129 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synergy CHC's current 14-Day RSI of 44.80 is 9.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Synergy CHC and its competitors. For the Medical Distribution industry, the median 14-Day RSI is 49.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synergy CHC's current 14-Day RSI is 44.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synergy CHC stock overvalued right now?
Based on GuruFocus' analysis, Synergy CHC (SNYR) is currently considered Possible Value Trap. The stock's GF Value™ is $1.08, compared to a current price of $0.11 — trading 90% below its estimated fair value. The current 14-Day RSI is 44.80 and 9.6% below the Medical Distribution industry median of 49.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Synergy CHC (SNYR), the current 14-Day RSI is 44.80 as of Sep. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer-branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen, amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNYR has been successfully added to your 
